Clark Estates Inc. NY Purchases 7,500 Shares of CVS Health Co. (NYSE:CVS)

Clark Estates Inc. NY raised its position in CVS Health Co. (NYSE:CVS - Free Report) by 19.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 45,375 shares of the pharmacy operator's stock after purchasing an additional 7,500 shares during the quarter. Clark Estates Inc. NY's holdings in CVS Health were worth $2,037,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health in the third quarter valued at about $25,000. Ridgewood Investments LLC increased its stake in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after buying an additional 450 shares during the period. Stonebridge Financial Group LLC acquired a new stake in shares of CVS Health in the fourth quarter valued at about $28,000. Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health in the third quarter valued at about $31,000. Finally, Financial Perspectives Inc increased its stake in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after buying an additional 466 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on CVS. StockNews.com raised CVS Health from a "sell" rating to a "hold" rating in a research note on Thursday, February 13th. Truist Financial increased their price target on CVS Health from $60.00 to $76.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Cantor Fitzgerald raised CVS Health from a "neutral" rating to an "overweight" rating in a research note on Wednesday, February 12th. Piper Sandler decreased their target price on CVS Health from $72.00 to $64.00 and set an "overweight" rating for the company in a research note on Monday, November 25th. Finally, Wells Fargo & Company raised their target price on CVS Health from $68.00 to $73.00 and gave the stock an "overweight" rating in a research note on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $69.83.

Remove Ads

Insider Buying and Selling

In related news, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Michael F. Mahoney purchased 30,000 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now directly owns 39,356 shares of the company's stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their position. The disclosure for this purchase can be found here. 0.24% of the stock is currently owned by corporate insiders.

CVS Health Stock Up 1.7 %

Shares of CVS stock traded up $1.09 during trading hours on Friday, reaching $66.34. The company had a trading volume of 10,082,148 shares, compared to its average volume of 11,965,158. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The business has a fifty day simple moving average of $56.42 and a 200-day simple moving average of $56.76. The company has a market cap of $83.64 billion, a price-to-earnings ratio of 18.12, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.01%. CVS Health's dividend payout ratio (DPR) is currently 72.68%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.